|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Top
Stories 27th
Annual Convention (7/25/08)
Convention
Lecture Legislation Journal
of the American Naturopathic Medical Association (JANMA) Facts |
Myomin and Angiostop: A Novel Combinational Therapy For Breast and Prostate Cancer Menopausal
Discomfort? No Sweat! A Hundred Patients in My First 100 Days ANMA 25th Annual Convention Lecture Schedule A Call For Validated Research Papers ANMA Photo I.D. Membership Cards NEW 2006 COLORS FOR CONVENTION!
To
advertise in the ANMA Monitor or ANMA MONITOR ONLINE
Please take the time to look over our sponsors!
The President's Corner By: Dr. Robert White for Dr. Charles Curtis Come one, come all, it’s that time again. It’s time to enjoy yourself while increasing your knowledge by attending ANMA’s 25th Annual Convention at the Riviera Hotel in Las Vegas, NV July 28, 29, 30. Enthusiasm is high, and we look forward to seeing you. All attendees will have the chance to win hundreds of dollars worth of prizes donated by our fine merchants for the "Super Raffle". ANMA will also hold a raffle with prizes including a weekend stay at the Riviera Hotel, Dinner and Show Tickets. Fun for all! Again this year we have invited political representatives who have an interest in natural health care. We will have the heads of legislative advocacy groups such as Coalition for Natural Health, and Health Keepers Alliance. There will be discussions on current licensing laws, commitment, and practice guidelines. The success ANMA has experienced in the past 25 years is due in part to: 1. its policy and dedication to naturopathic principles, 2. its strong leadership and, 3. the loyalty and involvement of ANMA members. Even though 25 years is a milestone to be celebrated, ANMA will continue until the work is finished. ANMA must remain vigilant in dealing with legislation around the country. The situation faced in Idaho today is a prime example why co-operation is not always a good policy. Colorado and New Mexico come to mind. Future planning and evaluation of goals will be a high priority at this 25th annual meeting. Every convention is a big event, full of opportunities to forge a better future. ANMA needs you to come and take part in this GRAND EVENT.
Foil To commemorate our 25th year of Success ANMA has decided to offer a special membership certificate that looks as beautiful as a work of art. Our already attractive membership certificate is now even more mesmerizing. This special membership certificate is foil embossed with not one but five vibrant and metallic colors. The price is only $75.00 with shipping included. I guarantee the new ANMA Certificate will be the best looking certificate on your wall. If you are not a 100% satisfied and as crazy as I am about this membership certificate, ANMA will gladly refund your money after the certificate has been returned. WARNING: If you place your certificate on the wall facing your desk, you’ll find yourself spending many hours staring at this beautiful work of art and won’t be able to get any work done. To order please call Julie Morgan at 702-897-7053 or e-mail us at webmaster@anma.com.
Myomin
and Angiostop: A Novel Combination Therapy By: Tsu-Tsair Chi, NMD, PhD
INTRODUCTION Cancer is a very invasive disease, not just physically but emotionally and financially as well. There are approximately 10.1 million Americans with a history of cancer and about 1.4 million more cancer cases are expected to be diagnosed this year1. While these figures seem astronomical, cancer mortality rates have been steadily decreasing in the last two decades, mainly due to advances in diagnosis and treatment methods. Two of the most common causes of cancer deaths are breast and prostate cancer. In 2006, about 214,640 new breast cancer cases (both men and women) are expected while 234,460 new prostate cancer cases are estimated1. The prognosis of those who suffer from these diseases depends largely on their treatment method. Traditionally, chemotherapy is the first treatment of choice by doctors. But recently, two types of therapy have shown major progress in increasing survival in cancer patients: aromatase inhibitors and angiogenesis or receptor tyrosine kinase (RTK) inhibitors. This combination is particularly relevant for breast and prostate cancer, both of which are estrogen-related. Aromatase expression promotes estrogen production, especially at the site of estrogen-responsive tumors such as in breast, ovarian2,3 and prostate cancer4,5. Aromatase inhibitors seek to block the aromatase enzyme from converting androgens into estrogen. This will diminish estrogen production, eventually leading to tumor suppression and apoptosis. Angiogenesis and RTK inhibitors work by blocking certain proteins overexpressed by cancer cells and which promote tumor growth. They selectively attack cancer cells and leave healthy cells unharmed. These types of drugs have shown favorable results in many types of cancer, most notably in solid tumors such as breast cancer. Two natural supplements show a very promising future as natural alternatives to aromatase and angiogenesis/RTK inhibitor drugs in the market today. Myomin©, a combination of herbs, has been shown to inhibit aromatase in vitro and in vivo. Furthermore, it has been used effectively for cysts and fibroids in humans6. A sea cucumber extract, Angiostop©, has exhibited in vitro and in vivo anti-angiogenic properties7-11.
Angiostop© and Myomin© combination for breast and prostate cancer
Myomin© inhibits aromatase The aromatase enzyme contributes to the production of estrogen through two pathways: androstenedione to estrone and testosterone to estradiol (Figure 1). By inhibiting these two pathways, estrone and estradiol (both carcinogenic forms of estrogen) levels are reduced and the production of estriol, the good estrogen, is continued. This is especially important in men because, as they get older, an increasing amount of testosterone is being converted into estradiol, leading to problems such as prostate cancer and decreased libido. Those who are using progesterone supplements should also be aware that the hormone can eventually be synthesized into estradiol and estrone (Figure 1) and create problems. For this reason, an aromatase inhibitor should be taken with the progesterone to prevent an increase in estrogen from progesterone use.
Figure 1. Biochemical pathways of reproductive hormones Myomin© is a combination of different herbs shown to inhibit the aromatase enzyme and consequently reduce estrogen levels. In rat endometrial and ovarian tissues, Myomin© was shown to reduce aromatase expression tremendously after 28 days of administration6. In one study, the estrogen-reducing action of Myomin© was evident, this time on postmenopausal women with fibroids and cysts. Sixty women were involved with an average estradiol (the most potent form of estrogen) level of 74.52 pg/ml. After 10 days on Myomin©, their average estradiol level reduced to 38.84 pg/ml. The size of the fibroids/cysts, as well as the pain associated with them, was also diminished6. Another study illustrates that Myomin© is effective in cysts, another estrogen-mediated condition. This study involved 85 pre- and postmenopausal women with ovarian cysts. After 1 to 3 courses of Myomin, the cysts and symptoms of 15 patients completely cleared with no recurrence 3 months after the study while 34 women experienced a 50% reduction in the size of the cyst6. Inhibiting aromatase and reducing estrogen levels do have a significant effect on estrogen-mediated growths, as illustrated in the following study. Fifty cases of fibrocystic breasts (45 women and 5 men) were treated with Myomin© for one month. Sixty five percent of the women were under 35 years old. In 14 cases, the growth cleared completely while the fibrocystic breast reduced by 50% in 16 cases. Of the five men in the study, the cyst cleared completely in 3 cases6.
Angiostop© inhibits angiogenesis and RTK Angiostop© contains the active ingredient Philinopside A, which has been shown through various studies to inhibit four different RTKs: vascular endothelial growth factor receptor (VEGFR), epidermal growth factor receptor (EGFR), platelet-derived growth factor receptor (PDGFR) and fibroblast growth factor receptor (FGFR)7. The number of RTKs it targets is significant because angiogenesis, or new blood vessel formation, is a complex process that likely involves multiple RTK signaling pathways. Inhibiting more than one RTK may prove to be more effective in blocking angiogenesis and other processes involved with cancer (Figure 2).
Figure 2. Angiostop© mechanism The VEGFR is of particular importance because VEGF is specifically associated with vascularity and is highly expressed in solid tumors such as breast and prostate cancer. Results of clinical trials indicate that addition of a VEGFR inhibitor to standard cancer therapy produces better survival rates than standard cancer therapy alone. Even when given by itself, a VEGFR inhibitor produces better results on patients with no prior treatment12. In studies, Angiostop© was shown to inhibit VEGFR with an IC50 of 2.6mM, comparable to that of SU5416 (semaxanib), a selective VEGFR inhibitor drug with an IC50 of 2.9mM8. This means that angiogenesis can be effectively stopped, cutting off nutrient and blood supply to the tumor and eventually causing it to die. Angiostop©’s effect was evident in the case of a 42-year-old woman from Florida who tested positive on a mammogram and ultrasound (Figure 3a). Through thermal imaging performed by Medi-Therm Imaging, angiogenesis evidently increased around the tumors from April to June, 2005 (Figure 3b), during which time she did not undergo any type of treatment. Beginning June 28, 2005, she took Angiostop© and the result has been remarkable. It appears that angiogenesis has significantly receded after two months of taking Angiostop© (Figure 3c). Figure 3a. April 11, 2005
Figure 3b. June 28, 2005
Figure 3c. August 24, 2005
Further studies support Angiostop©’s anti-angiogenesis activity in vivo. Two mouse models were employed: one with tumors induced by implanting sarcoma 180 cells, the other with tumors induced by hepatoma 22 cells. Administration of Angiostop© for 7 days at concentrations of 2, 3 and 4 mg/kg inhibited sarcoma 180 tumor growth by 28.2, 55.6, and 60.7%, respectively. In the other group, administration of 1, 2, and 3 mg/kg Angiostop© for 7 days suppressed hepatoma 22 tumor growth by 20.6, 46.1 and 59.4%, respectively8. Inhibiting angiogenesis alone can be effective in some cases of cancer. But for breast and prostate cancer, addition of an aromatase inhibitor may prove to be a more effective regimen because many aspects of the cancer are being targeted at the same time. First, the formation of blood vessels that feed the tumor is prevented. Second, by precluding the action of aromatase, estrogen production is greatly diminished, helping prevent the proliferation of tumor cells.
Discussion Treatment with either an angiogenesis or an aromatase inhibitor by itself certainly has merit. But combining both therapies, particularly for estrogen-responsive diseases like breast and prostate cancer, has such tremendous potential success that it should be considered a standard combination of treatment. Reiterating what was mentioned in an earlier section, this combination of therapies deals with many facets of breast and prostate cancer. Obviously, the growth of the tumor should be suppressed to prevent it from getting worse and spreading to other tissues. An angiogenesis inhibitor like Angiostop© will manage that issue. By inhibiting the VEGFR, it blocks the RTK directly associated with new blood vessel formation and accordingly cuts off the nutrient and blood supply to the tumor. But because Angiostop© also inhibits three other RTKs, it may produce a more complete and long-term anti-angiogenic effect than other therapies that target only one RTK. In the last decade, several RTK inhibitor drugs have been approved for treatment of different types of cancer. Among these are Avastin© (bevacizumab), a VEGFR inhibitor for colorectal cancer; Gleevec© (imatinib), which inhibits PDGFR and Bcr-Abl for leukemia and gastrointestinal stromal tumor (GIST); Tarceva© (erlotinib), an EGFR inhibitor for non small cell lung carcinoma and pancreatic cancer; Herceptin© (trastuzumab), an EGFR and HER2 inhibitor for breast cancer; and Sutent© (sunitinib), a multi-RTK inhibitor for GIST and advanced kidney cancer. It is apparent that some types of cancer express different RTKs. For example, colorectal cancer expresses both VEGFR and EGFR. Breast cancer also expresses EGFR, HER2 and possibly VEGFR. Therefore, inhibiting one RTK may not be enough to completely suppress the tumor. A wide-range RTK inhibitor like Angiostop© is more likely to produce better results in blocking angiogenesis and preventing invasion and metastasis. Aromatase inhibition is another aspect targeted by the combinational therapy. A major portion of breast cancer cases are estrogen-responsive and will therefore benefit from treatments that reduce estrogen production: treatments such as aromatase inhibitors. In fact, aromatase inhibitors are considered "critically important" for improving breast cancer outcomes13. Although aromatase activity has been detected in malignant prostate cancer tissues, the use of aromatase inhibitors as standard prostate cancer treatment is not yet considered the norm. But they are currently being explored as potential therapy because of emerging research linking aromatase expression, estrogen dominance and prostate cancer. In recent years, aromatase inhibitors have been more widely used than other hormone-related therapy for breast cancer. Antagonizing the effect of estrogen used to be the main objective of these therapies rather than lowering estrogen levels. Most notable among drugs with this mechanism is Tamoxifen©. Latest studies, however, have shown that long-term use of Tamoxifen© provides no apparent benefits. Aromatase inhibitors, on the other hand, produce better long-term effects and improve quality of life13. Arimidex© (anastrozole), Aromasin© (exemestane) and Femara© (letrozole) are just some of the aromatase inhibitor drugs in the market today. The drawback to these drugs, however, is that they are indicated for postmenopausal women only. Myomin©, on the other hand, can be used by men as well as pre- and postmenopausal women. In the study on fibrocystic breasts, a majority of the women in the study were premenopausal, demonstrating that Myomin© is not limited to postmenopausal women. It was also effective in three of the five men in the study. Furthermore, it was shown to be effective on cysts in both pre- and postmenopausal women. Recently, researchers have found that estrogen increased VEGF levels in normal breast tissue, promoting angiogenesis14. Further investigation is certainly warranted to establish the direct link between estradiol and VEGF. But if this is indeed true, then the use of an angiogenesis and aromatase inhibitor is even more imperative to achieve more comprehensive and effective results. For more information, please call (714) 777-1542.
Menopausal Discomfort? No
Sweat! By: Sydney Ross Singer and Soma Grismaijer
Women in Fiji have it easy, at least when it comes to menopause. We were in Fiji to study bra wearing and breast cancer, but took advantage of the opportunity of being with these non-western people to ask about the way local women experienced menopause. Margaret Mead, the famous cultural anthropologist, discovered that the discomforts young western women often associate with the "coming of age" were mostly absent for Samoan women. As medical anthropologists, we wondered if the coming "out of age" was any different for Fijian women than for those in the west who complain of various symptoms, such as hot flashes and profuse sweating. So we asked some post-menopausal women how they experienced their menopause. The response was pretty similar from each. "What’s that?" they asked, perplexed. We soon discovered that there is no equivalent word in Fijian for "menopause". In Fiji, when a women lives long enough to stop menstruating, she simply goes to the doctor to make sure she is not pregnant. Once she is assured this is not the case, she is happy and carefree. The lack of negative physiological and psychological effects, so troublesome for some western women, has resulted in the absence of a term to describe this time in a Fijian woman’s life. The hot flashes and profuse sweating of menopause is therefore not universal among all cultures. And in western cultures, it is not even universal among all women. While the medical literature has harped on lack of estrogen and excessive gonadotropic hormones as the most likely causes of this "pathology", the fact that most women who pass through menopause have little or no problem at all suggests that the mechanism for the reported problems must be something other than altered endocrinology post-menopause. In other words, since all women have reduced estrogen and elevated gonadotropins as they enter menopause, why do some women have troubling hot flashes and sweats, while others do not? Could there be another mechanism that has been overlooked? Perhaps the solution lies in the way we are conceptualizing menopausal "symptoms". We already realize that many so-called "symptoms" of disease are actually the body’s way to defend itself. Hence, a fever, often regarded as a symptom of illness, is actually part of the process of immune response. Coughing, vomiting, diarrhea, and nausea can also be regarded as defense mechanisms. Could hot flashes and sweats be a defense mechanism, as well? It was this line of thinking that led us to start the Menopause Relief Project, which included a preliminary study of menopausal women with hot flashes and sweats that no treatment would cure. Here is the theory behind the study. One of the most critical functions of the human body is to eliminate waste. We do this through several primary pathways: the lungs; the intestines; the skin; and the kidneys. One other mechanism is typically overlooked, and is only available to women. That is, elimination via menstruation and the sloughing off of the endometrium. The purpose of the endometrium, of course, is to provide nutritional support for a fertilized ovum until the placenta develops and takes over. The endometrium lining of the uterus is rebuilt following the previous menstrual flow under the influence of estrogen and progesterone. The thickness of the endometrium increases as blood vessels and tissue proliferate, while the endometrium soaks in nutrients like a sponge. Some nutrients are secreted, while others are stored for later use. Naturally, a highly vascular, secretory organ like the endometrium can also absorb and secrete (excrete) toxins, as well. Meanwhile, another effect of estrogen makes toxins especially available for absorption by the endometrium. One physiological effect of estrogen is to cause salt and fluid retention, making the entire body slightly swell just prior to the commencement of the period. This essentially flushes the tissues, as the fluid cleanses the interstitial spaces. This helps remove toxins from the tissues, as the fluid travels back into the bloodstream via the lymphatic channels for toxin elimination. It is at this time that some women experience PMS, or pre-menstrual syndrome. Leg, breast and abdominal swelling are manifestations of estrogen mediated fluid retention. Depression, irritability, confusion, and fatigue, also PMS symptoms, may be related to the increase in circulating toxins released from the tissues. As these toxins circulate in the bloodstream, some are eliminated by the kidneys, some are processed by the liver and excreted with the bile into the intestines, some are exhaled by the lungs, and some are sweated out. Many women report increased body odor and bad breath during this toxic time. Meanwhile, some toxins are absorbed by the receptive and "hungry" endometrium. If pregnancy is not achieved, the endometrium is sloughed off, eliminating the toxins with the unneeded uterine lining. Menstruation, then, is a time of cleansing for women of childbearing age. What happens when this mechanism stops at menopause? Clearly, if there is a reduction of one mode of elimination, the other modes must take the burden. This means that it would be important for menopausal women to move their bowels regularly, drink plenty of fluids and urinate when needed, breathe deeply, and perspire freely. And here is where western women have trouble. Many western women, as well as men, hold in their urge to urinate or defecate. This usually has to do with the reality of modern, urban life, with few available public toilets, and with those that are available often unacceptable for use. (More on this point in a future article.) Deep breathing is difficult for women with a tight bra strapped to their chests. As for sweating, our culture is extremely sweat-phobic. Besides the smell of sweaty armpits, there is the armpit stain on shirts and blouses to worry about. While this is not an issue for women in Fiji, who perspire freely, most western women use antiperspirants to deal with this. This may make their armpits more culturally acceptable, but it does so at the price of eliminatory efficiency. So here we have women who are holding in their waste and impairing their ability to sweat. On top of this, they stop menstruating. The outcome is an accumulation of toxins in the body. Over time, these toxins cause irritability and moodiness. Eventually, the toxins build up to the danger point, compelling the body to take matters in its own hands, so to speak. To eliminate the toxins, the body makes itself sweat. This, we believe, is the reason for the hot flashes. These are the body’s way of jump starting a sweat. Hot flashes can happen any time, and sometimes stop for months to only start again. Could it be that the hot flashes, and the sweat response this produces, are the means to eliminating toxins that have accumulated as a result of menopause, along with a hampered toxin disposal system? If this were the functional "purpose" of menopausal hot flashes and sweats, it follows that women could avoid the spontaneous sweats by deliberately sweating each day to eliminate the toxins. After all, the problem with hot flashes is that they happen at inconvenient times, out of the control of the woman. If she can choose the time when she wishes to eliminate toxins, it would make spontaneous sweating unnecessary, ending the hot flashes. To test this theory, we found 10 volunteers who were menopausal, experiencing very distressing hot flashes and sweats. We asked the local YWCA to provide free passes for these women to use the sauna and steam room, and asked the volunteers to take 20 minute sweats daily, for 8 weeks. We relied on their subjective responses for the results. By the end of the first week, 4 of the women had dropped out. They reported that they personally disliked sweating and found this form of prevention unappealing. All of these women continued to have hot flashes and spontaneous sweats. Of the remaining 6, one could not sweat effectively, and merely overheated in the sauna. She also dropped out. Of the remaining 5, all experienced relief by 2 weeks of daily sweats. They reported that they no longer had night sweats or hot flashes, apart from a minor blush. We later discussed our study with an AIDS researcher who was exploring hyperthermia treatments. He said that a side effect of the hyperthermia, which caused sweating, was that it stopped AIDS patients from having night sweats. We would like to see further research done on this, and encourage physicians to try this out with their patients. Most women can withstand the rigors of a sweat bath, but some conditions may contraindicate hyperthermia treatment, such as heart disease, hypertension, diabetes, etc. The women should also be told to replace fluids as needed, with electrolytes as well as water. This relationship between the need to sweat and the development of hot flashes may help explain a mechanism by which estrogen replacement reduces hot flashes. Estrogen replacement regimens call for three weeks on and one week off the hormone. This causes the body to retain fluid when the estrogen is high, and then release the fluid from the tissues as the estrogen falls, effectively functioning as a tissue cleanse. However, the potential cost of using estrogens is high. It can include cancer of the breast, cervix, vagina, endometrium, and liver, as well as gallbladder disease, stroke and pulmonary embolism, and exacerbated migraines, asthma, epilepsy, heart disease, and kidney disease. Perhaps it’s better to listen to the body and simply sweat to relieve and prevent menopausal discomfort. It is also easier on the millions of pregnant horses that are immobilized and catheterized to collect their urine for the drug Premarin (Previously Mare Urine). Clearly, women with menopausal problems need to examine their diet, along with the health and function of all their eliminatory organs. However, when we realize that menopause is not a disease, and that the body knows how to deal with disturbances to its equilibrium with mechanisms such as perspiring, understanding the cause of menopausal discomfort is really no sweat! We discuss our research, along with other elimination issues, in our book, Get It Out! Eliminating the Cause of Diverticulitis, Kidney Stones, Bladder Infections, Prostate Enlargement, Menopausal Discomfort, Cervical Dysplasia, PMS, and More (ISCD Press, 2001). We also have Self Studies for people to try for themselves at our website, www.SelfStudyCenter.org.
A Hundred
Patients in My First 100 Days By: Misty Cole, CHNP
I have evaluated many weight loss programs and heard many "horror stories" from my patients about their failed attempts to lose weight and keep it off. I have also heard stories from my peers about all the challenges involved in finding a weight loss program that is consistently effective, simple, and yet profitable. When my mentor invited me to explore Ultra Lite, the Professional Weight Loss and Maintenance System from Transformations, I was constructively skeptical. However, when I compared the Ultra Lite program to all the other major programs on the market, I found it to be a very nutritional sound program that was consistent with the principles of my naturopathic training. I could tell that Transformations was a different kind of company because they actually began from the very beginning to coach me on the best way to grow my weight loss practice. They provided turnkey marketing plans, material and one-on-one guidance. So initially, I developed my Weight Loss for Life practice by attracting a steady stream of patients from a local fitness center for women. These women had joined the gym to lose weight but they were not able to exercise effectively because, like so many Americans, they were carrying significant excess body fat and suffering from a poorly functioning metabolism. I have been consistently able to use the award-wining fat loss system to help the gym members safely lose 12-20 pounds of excess fat in 5 weeks, while preserving the lean muscle mass they need to benefit from the fitness activities provided at the gym. These extraordinarily consistent results have provided an ongoing stream of referrals across a large percentage of the gym membership. I have used the Transformations’ weight maintenance program to empower the gym members to keep the weight off and many of them have become my ongoing nutritional therapy patients. The fitness center owner quickly recognized the benefits of this true partnership with me; our partnership not only delivered energized gym members with their lean muscle mass intact so that they were now ready to take full advantage of the gym’s complementary fitness services, but it also provided innovative ways to attract new members to the fitness center using Transformations’ advertising materials. This provided a crucial competitive advantage for the gym owner for attracting new members as well as the financial rewards of more active members and a greatly reduced member retention problem. The rest of my patients have come from community activities, and turnkey advertising materials provided to me by Transformations. In addition to all the weight loss patient acquisition materials, I have used Transformations’ scientific referral system to ensure a steady stream of referrals from growing list of successful weight loss patients. Within the first 100 days of opening my practice, I achieved the remarkable milestone of serving 100 new patients with safe weight loss for life, one of the greatest gifts of health. The profitability of my Transformations business continues to be extraordinary. This special "partnership" arrangement between Transformations and my clinic, where a third party is focused on providing tools to help clinicians with both patient acquisition and profitability is unique in our industry and very much needed. I am happy to discuss my experiences and plans with other ANMA members at the 25th Annual Convention; if you would like to explore how Transformations’ business growth programs might just work for you, please join me at the Transformations’ Workshop on Saturday, July 29th at 3:00pm or stop by Booth 324. Best wishes for a worthwhile conference. Bio: Misty Cole is a Certified Natural Health Professional who started her practice in December 2005. She is the owner of Holistic Health Wellness Center and sole practioner in Harker Heights, Texas. She is in the process of completing her Doctor of Naturopath doctrine through Clayton College of Natural Health. Misty is a devoted wife and mother of three children aged 2-15. She is an active member in her church as well as their nutritional counselor. She has spoken at several women’s conferences regarding effective weight loss and wellness issues. She is the Chair for the Lampasas Independent School District School Health Advisory Board and an active Member in the local chapter of BNI (Business Networking, Inc.). She is an insulin-dependent diabetic who practices what she preaches. She has worked with her mother in her fight against stage-4 pancreatic cancer; given 3 months to live a year and a half ago, her mother is now cancer free with diet, herbs, and homeopathic therapy.
ANMA
25th Annual Convention
When you consider your future plans for adding equipment and skills to improve your business you should plan on attending the 25th Annual ANMA Convention and Educational Seminar. ANMA’s 24th Annual Convention was a huge success and this year’s convention is going to be even more electrifying. This year ANMA will have over 100 exhibitors representing every possible natural modality and the latest innovations in therapies and products to improve your practice. Last year exhibitors hosted a raffle and provided 100’s of free gifts for convention attendees. Many merchants also offered convention discounts on orders placed at the convention. In addition to the considerable number of exhibits, ANMA also provides an extensive three day lecture schedule. Knowing that education can be your greatest asset, ANMA gives you the opportunity to pick up your continuing education at our annual convention. The following is a preliminary schedule of the 2006 ANMA Educational Seminar: ANMA 25th ANNUAL CONVENTION AND EDUCATIONAL
SEMINAR FRIDAY July 28, 2006
SATURDAY July 29, 2006
SUNDAY July 30, 2006
SUNDAY July 30, 2006
SCHEDULE MAY BE SUBJECT TO CHANGE
A Call For Validated Research
Papers ? Are you a Natural Health Care Professional with a Research paper or Article that you would like to publish? ? Are you a Naturopathic or Natural Health Care student with an excellent class project / or thesis? ? Are you an instructor teaching the most current natural healthcare skills? GET ON TARGET FOR 2006 The ANMA Monitor is a widely distributed newsletter to healthcare professionals and naturopathic students. If you would like to submit an article, or know of someone that would be interested, now is the time to do so! You are invited to submit an article or case study to be featured in the ANMA Monitor. Submit your article according to the following standards: The ANMA Monitor is published quarterly by ANMA, P.O. Box 96273, Las Vegas, Nevada 89193 (702) 897-7053. Deadlines for articles and advertisements are November 20, March 20, June 20, and September 20 . Please submit articles on a IBM compatible 3.5" disk or by e-mail to webmaster@anma.com, clearly identified as an article for the ANMA Monitor. The editor reserves the right to edit any portion of an article before publishing. The editor also reserves the right to refuse articles which he deems inappropriate for this publication. We appreciate those who have already sent in articles. Take advantage of this opportunity to be in print!
ANMA Photo I.D. Membership Cards
ANMA for the first time, offers a remarkably new Photo I.D. Membership Card. The fresh new card will be in full color (including picture) and double sided. The front side will have the ANMA insignia, photograph, membership type, member I.D. number, and date joined. The back side of the card is bestowed with ANMA’s Code of Ethics. In addition, the Photo I.D. card is laminated for long lasting durability. The new Photo I.D. Membership Card cost is $35.00 and shipping is free of charge. For more information or to place an order, please call 702-897-7053 or e-mail us at webmaster@anma.com.
ANMA Embroidered Polo Shirts, New 2006 Convention Colors! As you may already know, ANMA offers a wide assortment of stylish accessories. Many of you have at least one or even two ANMA embroidered polo shirts. In the past ANMA has offered the polo shirts in a variety of colors, White, Black, Burgundy, Forest Green and Navy Blue. Now, ANMA is introducing two new colors, Steel Gray AND Putty. The polo shirts are of excellent quality (heavy 100% cotton with quality buttons) and look absolutely beautiful. In addition, ANMA has black tote bags with our logo embroidered on the side and lapel pins with optional tie chain. The tote bags and lapel pins cost $15.00 and shipping is provided free of charge (tote bags & lapel pins only). Every order will be processed and mailed as quickly as possible. All orders will be shipped Priority Mail to ensure speedy delivery. ANMA offers its polo shirts for only $28.00 plus shipping. The sizes we have range from small to triple extra large. If you would like a 2xl or 3xl, please add $1.00 and $2.00 respectively. If you have any questions or want to place an order, e-mail me at: webmaster@anma.com or call Julie Morgan at (702) 897-7053 or mail to ANMA, P.O. Box 96273, Las Vegas, NV 89193. NOTE: BE SURE TO ORDER NOW BEFORE THE CONVENTION TO GET THE SIZE AND COLOR YOU WANT. THE NEW 2006 COLORS WILL DEFINITELY BE VERY LIMITED OR EVEN SOLD OUT AFTER THE CONVENTION.
The views and opinions expressed in this online newsletter are not necessarily those of the American Naturopathic Medical Association, its officers or its members, nor are they necessarily in accordance or agreement with its policies. ANMA
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
